Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close

You Browsed By:

You Searched For:

Corporates

The product image can not be displayed.

Research and analysis on public companies and their debt instruments.

 

Highlights

  • 20 Jul 2016
    • US branded drug manufacturers face event risk from patent reviews
      The risks of inter partes reviews (IPR) for makers of branded drugs will emerge over the next 12 to 18 months. Although the invalidation of a patent or patent claim as a result of the procedure won’t necessarily lead to immediate generic competition, many drugs still face significant shortening of their patent lives due to IPR... Full Report l Press Release
  • 13 Jul 2016
    • Multiemployer pension plans remain substantially underfunded
      US multiemployer pension plans (MEPPs) remain substantially underfunded, threatening the viability of the Pension Benefit Guaranty Corporation’s (PBGC) insurance fund and potentially putting a financial strain on company sponsors. In an analysis of 124 MEPPs, we found that the plans were underfunded by a combined $337 billion at the end of 2014, equating to an average funding ratio of only about 47%... Full Report l Press Release
  • 12 Jul 2016
    • Brexit won't trigger spike in defaults; Commodities sector will remain stressed
      The global speculative-grade default rate continues to climb, driven by the stress that low commodity prices are putting on issuers in the sector. The UK's decision to leave the EU is unlikely to have a significant impact on corporate defaults. Most central banks are keeping accommodative monetary policies post-Brexit to ensure capital markets have sufficient liquidity…Press Release l Full Report
Research
Organizations
Please refine your search by Market Segment to get corresponding Rating Activity and Watchlist
Complete Your Profile
Please complete your profile before submitting your comments.
We're Sorry